Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Go back to Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
(NASDAQ: MIST) Delayed: 0.92 --0 (-0%)
Previous Close $0.92    52 Week High
Open $0.91    52 Week Low
Day High $0.94    P/E N/A 
Day Low $0.90    EPS
Volume 563,077